Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Urokinase biosimilar - Cerbios-Pharma

Next Previous
Search
Drug Profile

Urokinase biosimilar - Cerbios-Pharma

Alternative Names: HMW tc-uPA - Cerbios-Pharma; HMW-UK - Cerbios-Pharma; Recombinant human two chain high molecular weight urokinase - Cerbios-Pharma; Recombinant human urinary type plasminogen activator - Cerbios-Pharma; Recombinant urokinase - Cerbios-Pharma

Latest Information Update: 28 Aug 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Cerbios-Pharma
  • Class Granulocyte colony-stimulating factors; Plasminogen activator enzymes; Recombinant fusion proteins; Serine endopeptidases; Thrombolytics
  • Mechanism of Action Plasminogen activators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Vascular disorders

Most Recent Events

  • 28 Aug 2023 Preclinical development in Vascular-disorders in Switzerland (Cerbios-Pharma website; August 2023)
  • 28 Jun 2019 No recent reports of development identified for preclinical development in Vascular-disorders in Switzerland
  • 06 May 2015 Cerbios-Pharma has patent protection for Recombinant urokinase (Cerbios-Pharma website, May 2015)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top